Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 226

1.

D-cycloserine augmented exposure therapy for obsessive-compulsive disorder.

Kushner MG, Kim SW, Donahue C, Thuras P, Adson D, Kotlyar M, McCabe J, Peterson J, Foa EB.

Biol Psychiatry. 2007 Oct 15;62(8):835-8. Epub 2007 Jun 22.

PMID:
17588545
2.

D-cycloserine does not enhance exposure-response prevention therapy in obsessive-compulsive disorder.

Storch EA, Merlo LJ, Bengtson M, Murphy TK, Lewis MH, Yang MC, Jacob ML, Larson M, Hirsh A, Fernandez M, Geffken GR, Goodman WK.

Int Clin Psychopharmacol. 2007 Jul;22(4):230-7. Erratum in: Int Clin Psychopharmacol. 2007 Sep;22(5):312.

PMID:
17519647
3.

Augmentation of behavior therapy with D-cycloserine for obsessive-compulsive disorder.

Wilhelm S, Buhlmann U, Tolin DF, Meunier SA, Pearlson GD, Reese HE, Cannistraro P, Jenike MA, Rauch SL.

Am J Psychiatry. 2008 Mar;165(3):335-41; quiz 409. doi: 10.1176/appi.ajp.2007.07050776. Epub 2008 Feb 1.

PMID:
18245177
4.

Cognitive enhancers as adjuncts to psychotherapy: use of D-cycloserine in phobic individuals to facilitate extinction of fear.

Ressler KJ, Rothbaum BO, Tannenbaum L, Anderson P, Graap K, Zimand E, Hodges L, Davis M.

Arch Gen Psychiatry. 2004 Nov;61(11):1136-44.

PMID:
15520361
5.

A meta-analysis of D-cycloserine and the facilitation of fear extinction and exposure therapy.

Norberg MM, Krystal JH, Tolin DF.

Biol Psychiatry. 2008 Jun 15;63(12):1118-26. doi: 10.1016/j.biopsych.2008.01.012. Epub 2008 Mar 7.

PMID:
18313643
6.

Difficult-to-treat pediatric obsessive-compulsive disorder: feasibility and preliminary results of a randomized pilot trial of D-cycloserine-augmented behavior therapy.

Farrell LJ, Waters AM, Boschen MJ, Hattingh L, McConnell H, Milliner EL, Collings N, Zimmer-Gembeck M, Shelton D, Ollendick TH, Testa C, Storch EA.

Depress Anxiety. 2013 Aug;30(8):723-31. doi: 10.1002/da.22132. Epub 2013 May 30.

PMID:
23722990
7.

Augmentation of exposure therapy with D-cycloserine for social anxiety disorder.

Hofmann SG, Meuret AE, Smits JA, Simon NM, Pollack MH, Eisenmenger K, Shiekh M, Otto MW.

Arch Gen Psychiatry. 2006 Mar;63(3):298-304.

PMID:
16520435
8.

Cognitive-behavioural therapy with post-session D-cycloserine augmentation for paediatric obsessive-compulsive disorder: pilot randomised controlled trial.

Mataix-Cols D, Turner C, Monzani B, Isomura K, Murphy C, Krebs G, Heyman I.

Br J Psychiatry. 2014 Jan;204(1):77-8. doi: 10.1192/bjp.bp.113.126284. Epub 2013 Nov 21.

9.

A preliminary study of D-cycloserine augmentation of cognitive-behavioral therapy in pediatric obsessive-compulsive disorder.

Storch EA, Murphy TK, Goodman WK, Geffken GR, Lewin AB, Henin A, Micco JA, Sprich S, Wilhelm S, Bengtson M, Geller DA.

Biol Psychiatry. 2010 Dec 1;68(11):1073-6. doi: 10.1016/j.biopsych.2010.07.015.

10.

D-Cycloserine vs Placebo as Adjunct to Cognitive Behavioral Therapy for Obsessive-Compulsive Disorder and Interaction With Antidepressants: A Randomized Clinical Trial.

Andersson E, Hedman E, Enander J, Radu Djurfeldt D, Ljótsson B, Cervenka S, Isung J, Svanborg C, Mataix-Cols D, Kaldo V, Andersson G, Lindefors N, Rück C.

JAMA Psychiatry. 2015 Jul;72(7):659-67. doi: 10.1001/jamapsychiatry.2015.0546.

PMID:
25970252
11.

D-cycloserine augmentation in behavioral therapy for obsessive-compulsive disorder: a meta-analysis.

Xia J, Du Y, Han J, Liu G, Wang X.

Drug Des Devel Ther. 2015 Apr 21;9:2101-17. doi: 10.2147/DDDT.S68994. eCollection 2015. Review.

12.

Need for speed: evaluating slopes of OCD recovery in behavior therapy enhanced with d-cycloserine.

Chasson GS, Buhlmann U, Tolin DF, Rao SR, Reese HE, Rowley T, Welsh KS, Wilhelm S.

Behav Res Ther. 2010 Jul;48(7):675-9. doi: 10.1016/j.brat.2010.03.007. Epub 2010 Mar 16.

PMID:
20362975
13.

Effects of D-cycloserine on extinction: translation from preclinical to clinical work.

Davis M, Ressler K, Rothbaum BO, Richardson R.

Biol Psychiatry. 2006 Aug 15;60(4):369-75. Review.

PMID:
16919524
14.

A randomized placebo-controlled trial of D-cycloserine to enhance exposure therapy for posttraumatic stress disorder.

de Kleine RA, Hendriks GJ, Kusters WJ, Broekman TG, van Minnen A.

Biol Psychiatry. 2012 Jun 1;71(11):962-8. doi: 10.1016/j.biopsych.2012.02.033. Epub 2012 Apr 4.

PMID:
22480663
15.

A randomized controlled trial of the effect of D-cycloserine on exposure therapy for spider fear.

Guastella AJ, Dadds MR, Lovibond PF, Mitchell P, Richardson R.

J Psychiatr Res. 2007 Sep;41(6):466-71. Epub 2006 Jul 10.

PMID:
16828803
16.

Critical parameters for D-cycloserine enhancement of cognitive-behaviorial therapy for obsessive-compulsive disorder.

Rothbaum BO.

Am J Psychiatry. 2008 Mar;165(3):293-6. doi: 10.1176/appi.ajp.2007.07121871. Review. No abstract available.

PMID:
18316423
17.

EFFECTS OF HOMEWORK COMPLIANCE ON COGNITIVE-BEHAVIORAL THERAPY WITH D-CYCLOSERINE AUGMENTATION FOR CHILDREN WITH OBSESSIVE COMPULSIVE DISORDER.

Olatunji BO, Rosenfield D, Monzani B, Krebs G, Heyman I, Turner C, Isomura K, Mataix-Cols D.

Depress Anxiety. 2015 Dec;32(12):935-43. doi: 10.1002/da.22423. Epub 2015 Sep 15.

PMID:
26372401
18.
19.

Effects of D-cycloserine on extinction of learned fear to an olfactory cue.

Weber M, Hart J, Richardson R.

Neurobiol Learn Mem. 2007 May;87(4):476-82. Epub 2007 Feb 1.

PMID:
17275356
20.

A pilot study of the effectiveness of D-cycloserine during cue-exposure therapy in abstinent alcohol-dependent subjects.

Watson BJ, Wilson S, Griffin L, Kalk NJ, Taylor LG, Munafò MR, Lingford-Hughes AR, Nutt DJ.

Psychopharmacology (Berl). 2011 Jul;216(1):121-9. doi: 10.1007/s00213-011-2199-2. Epub 2011 Feb 12.

PMID:
21318564
Items per page

Supplemental Content

Write to the Help Desk